VIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors to Contact the Firm

Core Viewpoint - Kaskela Law LLC is investigating the fairness of the proposed buyout of Vigil Neuroscience, Inc. by Sanofi, focusing on whether shareholders are receiving adequate compensation for their shares [1][3]. Buyout Details - Vigil Neuroscience has agreed to be acquired by Sanofi for an upfront price of $8.00 per share in cash, along with a contingent value right (CVR) worth an additional $2.00 upon achieving certain milestones [2]. - Following the transaction, Vigil's shares will no longer be publicly traded, and shareholders will be cashed out of their investment positions [2]. Investigation Focus - The investigation aims to determine if Vigil's investors are receiving sufficient monetary consideration and whether the company's officers or directors breached fiduciary duties or violated securities laws in agreeing to the buyout price [3]. - Analysts had set price targets for Vigil's shares exceeding $13.00 at the time of the announcement, raising questions about the adequacy of the buyout offer [3].